Neuropsychiatric complications of efavirenz in children with HIV infection

被引：2

作者：

Hammond, Charles K. ^{[1
]}

Eley, Brian ^{[2
]}

Wilmshurst, Jo M. ^{[1
]}

机构：

[1] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat Neurol, ZA-7700 Rondebosch, South Africa

[2] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, ZA-7700 Rondebosch, South Africa

来源：

FUTURE VIROLOGY | 2016年 / 11卷 / 06期

关键词：

adverse events; children; efavirenz; HIV; neuropsychiatric; HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE INHIBITORS; NAIVE HIV-1-INFECTED PATIENTS; RANDOMIZED CLINICAL-TRIAL; CEREBROSPINAL-FLUID; PLASMA EFAVIRENZ; NEUROPSYCHOLOGICAL PERFORMANCE; NEUROLOGIC COMPLICATIONS; ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE;

D O I：

10.2217/fvl-2016-0030

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Efavirenz is an effective antiretroviral agent widely used as part of first-line regimen in HIV1-infected children and adults. Neuropsychiatric adverse effects are reported in up to 50% of users. These include dizziness, insomnia, abnormal dreams, headache and impaired concentration. The plasma level of efavirenz may be key in the development of these adverse effects. Even among individuals taking recommended doses for weight, the plasma levels vary widely. Genetic polymorphisms leading to different allelic variants of the CYP2B6 enzyme, making some individuals slow metabolizers may play a role. These allelic variants are highest in people of African descent. This report examines the neuropsychiatric adverse effects of efavirenz, and the strength of the data that the product may result in neuronal damage.

引用

页码：469 / 480

页数：12

共 79 条

[1]

[Anonymous], 2013, CONGUID UANT DRU

[2] Efavirenz and the CNS: what we already know and questions that need to be answered [J].

Apostolova, Nadezda ;

Funes, Haryes A. ;

Blas-Garcia, Ana ;

Galindo, Maria J. ;

Alvarez, Angeles ;

Esplugues, Juan V. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (10) :2693-2708

[3] Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV-1-Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis [J].

Behrens, Georg ;

Rijnders, Bart ;

Nelson, Mark ;

Orkin, Chloe ;

Cohen, Calvin ;

Mills, Anthony ;

Elion, Richard A. ;

Vanveggel, Simon ;

Stevens, Marita ;

Rimsky, Laurence ;

Thorpe, David ;

Bosse, Matthew ;

White, Kirsten ;

Zhong, Lijie ;

DeMorin, Jennifer ;

Chuck, Susan K. .

AIDS PATIENT CARE AND STDS, 2014, 28 (04) :168-175

[4] Dependence of Efavirenz- and Rifampicin-Isoniazid-Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia [J].

Bertrand, Julie ;

Verstuyft, Celine ;

Chou, Monidarin ;

Borand, Laurence ;

Chea, Phalla ;

Nay, Kuy Huong ;

Blanc, Francois-Xavier ;

Mentre, France ;

Taburet, Anne-Marie .

JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (03) :399-408

[5] Efavirenz concentrations in CSF exceed IC50 for wild-type HIV [J].

Best, Brookie M. ;

Koopmans, Peter P. ;

Letendre, Scott L. ;

Capparelli, Edmund V. ;

Rossi, Steven S. ;

Clifford, David B. ;

Collier, Ann C. ;

Gelman, Benjamin B. ;

Mbeo, Gilbert ;

McCutchan, J. Allen ;

Simpson, David M. ;

Haubrich, Richard ;

Ellis, Ronald ;

Grant, Igor .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (02) :354-357

[6] Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy [J].

Birbeck, G. L. ;

French, J. A. ;

Perucca, E. ;

Simpson, D. M. ;

Fraimow, H. ;

George, J. M. ;

Okulicz, J. F. ;

Clifford, D. B. ;

Hachad, H. ;

Levy, R. H. .

NEUROLOGY, 2012, 78 (02) :139-145

[7] Depressive symptoms predict increased incidence of neuropsychiatric side effects in patients treated with efavirenz [J].

Boly, Larry ;

Cafaro, Virginia ;

Dyner, Toby .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (04) :514-515

[8] Efavirenz Binding Site in HIV-1 Reverse Transcriptase Monomers [J].

Braz, Valerie A. ;

Barkley, Mary D. ;

Jockusch, Rebecca A. ;

Wintrode, Patrick L. .

BIOCHEMISTRY, 2010, 49 (49) :10565-10573

[9]

CDC, TB HIV COINF

[10] Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s) [J].

Clifford, David B. ;

Evans, Scott ;

Yang, Yijun ;

Acosta, Edward P. ;

Ribaudo, Heather ;

Gulick, Roy M. .

HIV CLINICAL TRIALS, 2009, 10 (06) :343-355

← 1 2 3 4 5 6 7 8 →